|
End-of-day quote
LUXEMBOURG S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 40.20 USD | -1.47% |
|
+0.50% | +33.11% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 45.94B | |||||
| 37.22B | |||||
| 12.06B | |||||
| 11.74B | |||||
| 9.03B |
Select your edition
All financial news and data tailored to specific country editions
